U.S. SEC Proposes New Share Repurchase/Buyback Disclosure Rules and Amendments to 10b5-1 Plan Regime

Dechert LLP

Key Takeaways

  • Share repurchase/buyback proposal would:
    • Establish new Form SR for reporting repurchases of equity securities registered under Section 12 of the Securities Exchange Act of 1934 by issuers and affiliated purchasers.
    • Require issuers to furnish a Form SR with the SEC before the end of the first business day following the day of the buyback date.
    • Expand existing periodic disclosure regarding share repurchases.
  • Rule 10b5-1 proposal would:
    • Add new conditions to the availability of the affirmative defense under Exchange Act Rule 10b5-1(c)(1), including minimum post-adoption cooling-off periods before trading can begin (120 days for directors and officers and 30 days for issuers), no overlapping Rule 10b5-1 plans for open market trades in the same class of securities, a limit of one single-trade plan per 12-month period and a requirement to operate (not just adopt) plans in good faith.
    • Create new certification and disclosure requirements regarding issuers’ insider trading policies and regarding the adoption and termination (including modification) of Rule 10b5-1 and certain other trading arrangements by directors, officers, and issuers.
    • Create new disclosure requirements for executive and director equity compensation awards granted during certain time periods.
    • Update Forms 4 and 5 to require Section 16 insiders to identify transactions made pursuant to a Rule 10b5-1(c)(1) trading arrangement and to disclose all gifts of securities on Form 4.

* * * * *

As expected,1 the U.S. Securities and Exchange Commission released two significant rule proposals for issuers on December 15, 2021—one regarding issuer share repurchases and the other regarding issuer and director and officer Rule 10b5-1 insider trading plans. The share repurchase proposal was approved by a three-to-two vote and the Rule 10b5-1 proposal was approved unanimously.2 The proposals are subject to a public comment period and final rulemaking.

Share Repurchase/Buyback Proposal

The SEC’s share repurchase proposal is premised on a concern that, although “there are legitimate business reasons for issuers to repurchase securities,”… “issuer repurchases could potentially be used to increase share prices in order to enhance executive compensation and insider stock value.” According to the SEC, these concerns, against the backdrop of an increasing volume of issuer share repurchases, suggest the need for expanded disclosure related to issuer share repurchases that “would allow [investors] to assess the impact of an issuer’s share repurchases on the issuer’s stock price.” Although many issuers are subject to existing quarterly disclosure obligations regarding their share repurchases, and many issuers voluntarily report information regarding their share repurchase plans, the proposal would require significantly more detailed, immediate and frequent disclosure.

New Exchange Act Rule 13a-21 and Form SR

The share repurchase proposal would add new Exchange Act Rule 13a-21 and Form SR3 that would require an issuer4 to report any purchase made by or on behalf of the issuer or any affiliated purchaser5 of shares or other units of any class of the issuer’s equity securities that is registered by the issuer pursuant to Exchange Act Section 12. The issuer would have to furnish a new Form SR before the end of the first business day following the day on which the issuer executes6 a share repurchase. The Form SR would require the following disclosure in tabular format, by date, for each class or series of securities:

  • Identification of the class of securities purchased;
  • The total number of shares (or units) purchased, including all issuer repurchases whether or not made pursuant to publicly announced plans or programs;
  • The average price paid per share (or unit);
  • The aggregate total number of shares (or units) purchased on the open market;
  • The aggregate total number of shares (or units) purchased in reliance on the Rule 10b-18 safe harbor; and
  • The aggregate total number of shares (or units) purchased pursuant to a plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Proposed Revisions to Item 703, Form 20-F, and Form N-CSR

The share repurchase proposal would amend Item 703 of Regulation S-K, with corresponding changes to Form 20-F and Form N-CSR, to require an issuer to disclose:

  • The objective or rationale for its share repurchases and process or criteria used to determine the amount of repurchases;7
  • Any policies and procedures relating to purchases and sales of the issuer’s securities by its officers and directors during a repurchase program, including any restriction on such transactions;
  • Whether it made its repurchases pursuant to a plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), and if so, the date that the plan was adopted or terminated;
  • Whether purchases were made in reliance on the Rule 10b-18 non-exclusive safe harbor;
  • Any policies and procedures relating to purchases and sales of the issuer’s securities by its officers and directors during a repurchase program, including any restrictions on such transactions.8

The proposal would also require that issuers check a box (added to the text that precedes the currently required tabular disclosure of issuer purchases of equity securities) if any of their directors or Section 16 officers purchased or sold shares or other units of the class of the issuer’s equity securities that is the subject of an issuer share repurchase plan or program within 10 business days before or after the announcement9 of an issuer purchase plan or program.

Rule 10b5-1 Proposal

Rule 10b5-1 under the Securities Exchange Act of 1934 provides directors, officers and issuers with an affirmative defense to Rule 10b-5 insider trading charges for trades made pursuant to a binding contract, an instruction to another person to execute the trade for the instructing person’s account, or a written plan, subject to several conditions.10

The basic concept behind the Rule 10b5-1 affirmative defense is simple: if an insider has no control over the stock sales and purchases (either because an external trading manager is used or because transactions occur according to a pre-determined formula), material non-public information cannot have been the basis for the transactions, and therefore no insider trading was committed. Similarly, to the extent a securities fraud class action points to a defendant’s purportedly “suspicious” stock trades in an attempt to raise a strong inference of scienter, a defendant may attempt to rebut such an inference by arguing that the trades were made pursuant to a Rule 10b5-1 plan.

In response to “concerns about abuse of the rule to opportunistically trade securities on the basis of material nonpublic information in ways that harm investors and undermine the integrity of the securities markets,”11 the Rule 10b5-1 proposal would add a number of conditions to the availability of the affirmative defense under Rule 10b5-1 and add a number of disclosure obligations.

Cooling-Off Condition

Currently, Rule 10b5-1(c)(1) does not impose any waiting period between the date the trading arrangement is adopted and the date of the first transaction to be executed under the trading arrangement. To “reduce the risk that an insider could benefit from any material nonpublic information of which they may have been aware at the time of adopting the trading arrangement,” the proposal would amend Rule 10b5-1(c)(1) to add as a condition to the availability of the affirmative defense: (1) a minimum 120-day cooling-off period after the date of adoption of any Rule 10b5-1(c)(1) trading arrangement (including adoption of a modified trading arrangement) by a director or officer12 before any purchases or sales under the new or modified trading arrangement; and (2) a minimum 30-day cooling-off period after the date of adoption of any Rule 10b5-1(c)(1) trading arrangement by an issuer before any purchases or sales under the new or modified trading arrangement. A “modification” of an existing Rule 10b5-1(c)(1) trading arrangement, including cancelling one or more trades, would be deemed equivalent to terminating the plan in its entirety, and the cooling-off period would therefore apply after a “modification” before any new trades could commence.

Certification Condition

To “reinforce directors’ and officers’ cognizance of their obligation not to trade or adopt a trading plan while aware of material nonpublic information, that it is their responsibility to determine whether they are aware of material non-public information when adopting Rule 10b5-1 plans, and that the affirmative defense under Rule 10b5-1 requires them to act in good faith and not to adopt such plans as part of a plan or scheme to evade the insider trading laws,” the proposal would amend Rule 10b5-1(c)(1)(ii) to provide that if a director or officer of the issuer of the securities adopts a Rule 10b5-1 trading arrangement, as a condition to the availability of the affirmative defense, such director or officer would be required to promptly furnish to the issuer a written certification at the time of the adoption of a new/modified trading arrangement stating:

  • That they are not aware of material nonpublic information about the issuer or its securities; and
  • That they are adopting the contract, instruction, or plan in good faith and not as part of a plan or scheme to evade the prohibitions of Exchange Act Section 10(b) and Exchange Act Rule 10b-5.

These personal certifications would not be required where a director or officer terminates an existing Rule 10b5-1 trading arrangement and does not adopt a new/modified trading arrangement for which the affirmative defense is sought. As proposed, there would be no requirement to file these certifications, but the director or officer would be required to retain a copy of the certification for a period of ten years.

No-Overlapping Trading Arrangements Condition and Single-Trade Plan Limit Condition

Currently, there is no limit on the number of plans or other Rule 10b5-1(c)(1) trading arrangements that a person can have in effect simultaneously. The proposal expresses concern that setting up multiple overlapping Rule 10b5-1(c)(1) trading arrangements could allow insiders to “exploit inside information by setting up trades timed to occur around dates on which they expect the issuer will likely release material nonpublic information” and to circumvent the proposed cooling-off period. In response, the proposal would amend Rule 10b5-1(c)(1) to eliminate the affirmative defense for trades under a trading arrangement when the trader maintains another trading arrangement, or subsequently enters into an additional overlapping trading arrangement, for open market purchases or sales of the same class of securities. This limitation would not apply to transactions where a person acquires (or sells) securities directly from the issuer, such as acquiring shares through participation in employee stock ownership plans or dividend reinvestment plans, which are not executed by the director or officer on the open market.

For similar reasons, the proposal would amend Rule 10b5-1(c)(1)(ii) so that the affirmative defense would not be available for a single-trade plan if the trader had, within a 12-month period, purchased or sold securities pursuant to another single-trade plan.13

Good Faith Operation Condition

Currently, Rule 10b5-1 requires that the contract, instruction, or plan to purchase or sell securities was “given or entered into” in good faith. To “help deter fraudulent and manipulative conduct and enhance investor protection throughout the duration of the trading arrangement,” the proposal would amend Rule 10b5-1(c)(1)(ii) to add the condition that a contract, instruction, or plan be “operated” in good faith. For example, the affirmative defense would not be available to a trader who:

  • Cancels or modifies their plan in an effort to evade the prohibitions of the rule; or
  • Uses their influence to affect the timing of a corporate disclosure to occur before or after a planned trade to make such trade more profitable or to avoid or reduce a loss.

New Item 408 Disclosure

Currently, there are no mandatory disclosure requirements concerning the use of Rule 10b5-1 trading arrangements or other trading arrangements by companies or insiders, and issuers are not required to disclose their insider trading policies or procedures. The proposal expresses concern that the lack of a disclosure requirement “deprives investors of the ability to assess whether those parties may be misusing their access to material nonpublic information” and makes it harder for investors to assess how the issuer “protects material nonpublic information from misuse.”14

Proposed Item 408(a) of Regulation S-K would require issuers to disclose in Form 10-Q and Form 10-K:15

  • Whether, during the issuer’s last fiscal quarter (the issuer’s fourth fiscal quarter in the case of an annual report), the issuer has adopted or terminated any contract, instruction or written plan to purchase or sell securities of the issuer, whether or not intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), and provide a description of the material terms of the contract, instruction or written plan, including:
    • The date of adoption or termination;16
    • The duration of the contract, instruction or written plan; and
    • The aggregate amount of securities to be sold or purchased pursuant to the contract, instruction or written plan.
  • Whether, during the issuer’s last fiscal quarter, any director or officer has adopted or terminated any contract, instruction or written plan for the purchase or sale of equity securities of the issuer, whether or not intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), and provide a description of the material terms of the contract, instruction or written plan, including:
    • The name and title of the director or officer;
    • The date on which the director or officer adopted or terminated the contract instruction or written plan;
    • The duration of the contract instruction or written plan; and
    • The aggregate number of securities to be sold or purchased pursuant to the contract, instruction or written plan.

In addition, proposed Item 408(b) of Regulation S-K would require an issuer, in its annual reports on Form 10-K and proxy and information statements on Schedules 14A and 14C,17 to disclose whether the issuer has adopted insider trading policies and procedures governing the purchase, sale, and other dispositions of the issuer’s securities by directors, officers, and employees or the issuer itself that are reasonably designed to promote compliance with insider trading laws, rules, and regulations, and any listing standards applicable to the issuer. If the issuer has adopted insider trading policies and procedures, it must disclose such policies and procedures.18 If the issuer has not adopted such insider trading policies and procedures, it must explain why it has not done so.

The proposal notes that Item 408(b) of Regulation S-K would not specify all details that an issuer should address in its insider trading policies, nor does it prescribe any specific language that such policies must include. The proposal suggests that such details may include: information on the issuer’s process for analyzing whether directors, officers, employees, or the issuer itself when conducting an open-market share repurchase have material nonpublic information; the issuer’s process for documenting such analyses and approving requests to purchase or sell its securities; or how the issuer enforces compliance with any such policies and procedures it may have, including through gifts of such securities.

The proposed Item 408 disclosures would be subject to the principal executive and principal financial officer certifications required by Section 302 of the Sarbanes-Oxley Act, and would be required to be tagged using Inline eXtensible Business Reporting Language.

New Section 16 Disclosure

Currently, persons subject to Section 16 reporting are required to disclose changes in their beneficial ownership on Form 4 or 5. Form 4 is due before the end of the second business day following the date of execution of the transaction it reports. Form 5 is not due until 45 days after year end.

The proposal would require a Form 4 or 5 filer to check a box on that form to indicate whether a sale or purchase reported on that form was made pursuant to a Rule 10b5-1(c) trading arrangement. Filers would also be required to provide the date of adoption of the Rule 10b5-1 trading arrangement, and would have the option to provide additional relevant information about the reported transaction. Forms 4 and 5 would also have a second, optional checkbox that would allow a filer to indicate whether a transaction reported on the form was made pursuant to a pre-planned contract, instruction, or written plan that is not intended to satisfy the conditions of Rule 10b5-1(c).

To address concerns the “length of the filing period for Form 5 may allow insiders to engage in problematic practices involving gifts of securities, such as insiders making stock gifts while in possession of material nonpublic information, or backdating a stock gift in order to maximize a donor’s tax benefit,” the proposal would amend Exchange Act Rule 16a-3 to require the reporting of dispositions of bona fide gifts of equity securities on Form 4 (instead of Form 5).

New Item 402 Disclosure

The proposal would add a new paragraph to Item 402 of Regulation S-K to address the SEC’s concern regarding the timing of option grants. The proposal notes that timing option grants to occur immediately before the release of positive material nonpublic information (“spring-loading”) can benefit executives with an option award that will likely be in-the-money as soon as the material nonpublic information is made public. Alternatively, if an issuer is aware of material nonpublic information that is likely to decrease its stock price, it may decide to delay a planned option award until after the release of such information (“bullet-dodging”).

Under the proposal, to identify if any such timed options are granted, a new paragraph would be added to Item 402 of Regulation S-K that would require tabular disclosure of each option19 award (including the number of securities underlying the award, the date of grant, the grant date fair value, and the option’s exercise price) granted to named executive officers20 within 14 calendar days before or after the filing of a periodic report, an issuer share repurchase, or the filing or furnishing of a current report on Form 8-K that contains material nonpublic information; the market price of the underlying securities the trading day before disclosure of the material nonpublic information; and the market price of the underlying securities the trading day after disclosure of the material nonpublic information.21

Under the proposed rule, disclosure would also be required of the grant date fair value of each equity award computed in accordance with FASB ASC Topic 718.

In addition, the proposed rule would require narrative disclosure about an issuer’s option grant policies and practices regarding the timing of option grants and the release of material nonpublic information, including how the board determines when to grant options and whether, and if so, how, the board or compensation committee takes material nonpublic information into account when determining the timing and terms of an award.

The proposal would require this disclosure in annual reports on Form 10-K, as well as in proxy statements and information statements related to the election of directors, shareholder approval of new compensation plans, and solicitations of advisory votes to approve executive compensation.22 For issuers that are subject to CD&A, the proposed narrative disclosure could be included in CD&A. The disclosure would be required to be tagged using Inline eXtensible Business Reporting Language.

Enforcement Activity

Rule 10b5-1, under the existing regulatory framework, does not provide an exemption from the federal securities laws prohibiting insider trading. Rather, it provides only an affirmative defense. Importantly, this affirmative defense is not available if the insider is in possession of material non-public information at the time the plan is implemented or revised, if the plan is not entered in good faith, or if the plan is part of a scheme to circumvent the insider trading rules. Indeed, the SEC has, and can, bring an enforcement action against an individual for insider trading even when the trades were made pursuant to a 10b5-1 plan.

In October 2010, for example, the SEC announced a landmark US$22.5 million negotiated penalty in an action against Angelo Mozilo, a corporate executive alleged to have “engaged in insider trading in the securities … by establishing four 10b5-1 sales plans in October, November, and December 2006 while he was aware of [material non-public information].” Mozilo agreed to the penalty after his attempt to dismiss the case in federal court was denied, with the district court judge holding that because the “plans [were] adopted or amended while Mozilo was in possession of material nonpublic information, … the SEC has adequately stated a claim for insider trading against Mozilo under Section 10(b) and Rule 10b-5.”23

More recently, in 2020, the SEC announced a US$20 million settlement in an action against an issuer involving accusations of the “improper initiation of, and repurchase of shares pursuant to, a [company’s] Rule 10b5-1 plan while in possession of [material non-public information].”24 However, in settling the case, the SEC found only that the issuer had “fail[ed] to devise and maintain a system of internal accounting controls sufficient to provide reasonable assurance that stock buyback transactions were executed in accordance with management’s authorization” in violation of Exchange Act Section 13(b)(2)(B).

Despite these high-profile exceptions, in general, however, there are few cases against insiders for insider trading when transactions were made pursuant to a plan.

Key Takeaways for Issuers

Although the proposals are subject to public comment and final rule action—and represent only the latest salvo in a years-long effort to address some of the perceived shortcomings of Rule 10b5-1 and its explicit mechanism for insiders to trade in the securities of the issuer, even when they are in possession of material non-public information about the issuer—it seems likely that many of the requirements will appear largely intact in the final rules. Accordingly, issuers should consider preparing in advance by:

  • Adding disclosure controls and procedures with respect to share repurchases;
  • Preparing the disclosure they would make in response to the new requirements;
  • Re-examining the sufficiency of their policies and procedures relating to the use of Rule 10b5-1 plans;
  • Providing additional training to officers and directors on the proper use of Rule 10b5-1 plans; and
  • Instituting additional conditions relating to Rule 10b5-1 plans meant to satisfy the proposed conditions and good faith operation requirement, which might include:
    • Requiring company approval of adoption of, or participation in, all trading plans and/or plan templates;
    • Imposing a cooling-off period between the establishment or modification of a plan and the first trade pursuant to the plan;
    • Prohibiting multiple or overlapping plans with respect to the same security;
    • Limiting the number of single-trade plans;
    • Avoiding a pattern of frequently adopting, amending, or cancelling plans;
    • Imposing mandatory minimum effective periods for trading plans during which such plans cannot ordinarily be modified.

Implications for Private Litigation

Finally, trading by insiders has frequently been fodder for class action plaintiffs seeking to establish scienter to support a broader securities fraud action and to survive a motion to dismiss. Courts have held that “the scienter requirement is met where the complaint alleges facts showing either: (1) a motive and opportunity to commit the fraud; or (2) strong circumstantial evidence of conscious misbehavior or recklessness” (e.g., in cases where defendants “benefited in a concrete and personal way from the purported fraud”).25 To the extent plaintiffs point to stock trades to support a strong inference of scienter, plaintiffs must allege that the trades were “unusual” or “suspicious.”26 Courts have held that this determination turns on a number of factors: (1) the amount of net profits realized from the sales; (2) the percentages of holdings sold; (3) the change in volume of insider defendant’s sales; (4) the number of insider defendants selling; (5) whether sales occurred soon after statements defendants are alleged to have known were misleading; (6) whether sales occurred shortly before corrective disclosures or materialization of the alleged risk; and (7) whether sales were made pursuant to trading plans such as Rule 10b5–1 plans.27 A defendant may attempt to rebut an inference of scienter by arguing that the trades were made pursuant to a Rule 10b5-1 plan. Thus, in this context, defendants are not limited to using a 10b5-1 plan as an affirmative defense; instead, a 10b5-1 plan may be used to undermine allegations on a motion to dismiss.28

Ordinarily, the use of a non-discretionary trading plan that sells fixed quantities of stock on pre-scheduled dates undermines any inference of scienter.29 However, courts have been willing to entertain arguments that the size and timing of sales pursuant to 10b5-1 trading plans can nevertheless support an inference of scienter. Similarly, plaintiffs have argued that where 10b5–1 trading plans are entered into during the class period, they may not be a cognizable defense to scienter allegations on a motion to dismiss as a “clever insider might maximize their gain from knowledge of an impending price drop over an extended amount of time, and seek to disguise their conduct with a 10b5–1 plan.”30 Recent criticism of Rule 10b5-1 by regulators, including Chair Gensler’s renewed efforts to amend the rule to address perceived abuses, will likely further strengthen class action plaintiffs’ arguments seeking to rebut defendants’ use of 10b5-1 trading plans in class action securities fraud cases.

Of course, if Rule 10b5-1 is amended as proposed, any perceived abuses are likely to be curtailed, and insiders who adhere to the more stringent requirements are likely to have an even better chance to defeat allegations of scienter where any trades at issue occurred pursuant to a properly implemented or amended Rule 10b5-1 trading plan.

Footnotes

1) On June 7, 2021, at the CFO Network Summit, Chair Gary Gensler delivered prepared remarks indicating this topic was a priority for him. On June 11, 2021, the SEC’s Office of Information and Regulatory Affairs released the Spring 2021 Unified Agenda of Regulatory and Deregulatory Actions, which included this topic among the proposed and final SEC rulemaking areas. On August 6, 2021, the Investor as Owner Subcommittee of the SEC Investor Advisory Committee released draft recommendations regarding Rule 10b5-1 plans. On September 9, 2021, Chair Gensler reiterated his concerns for the topic in his prepared remarks at the Investor Advisory Committee meeting.

2) Chair Gensler commented here, Commissioner Peirce commented here and here, Commissioner Roisman commented here, Commissioner Lee commented here and here, and Commissioner Crenshaw commented here and here.

3) Issuers would be required to furnish (rather than file) new Form SR, which means that issuers would not be subject to liability under Section 18 of the Exchange Act for the disclosure in the form, and that the information would not be deemed incorporated by reference into filings under the Securities Act and thus would not be subject to liability under Section 11 of the Securities Act, unless the issuer expressly incorporated such information. Also, a late submission of the form would not affect eligibility to use Form S-3 or to file a short-form registration statement under General Instruction A.2 of Form N-2.

4) As proposed, this would include a foreign private issuer and certain registered closed-end funds. There would be no exemption for non-accelerated filers, smaller reporting companies, or emerging growth companies. The requirement would not apply to business development companies.

5) The term “affiliated purchaser” has the same meaning as in the Rule 10b-18 context. The proposal covers purchases by affiliates of the issuer and purchases by any person acting on behalf of the issuer or an affiliated purchaser.

6) The execution date is the trade date—the point of a securities transaction at which the parties have agreed to its terms and are contractually obligated to settle the transaction—rather than settlement date. The proposal notes that issuers would have the ability to make corrections, if needed, in amended filings (for example, if the reported trade fails to settle).

7) Note that the proposal requested comment on whether this requirement is likely to lead to boilerplate disclosure. Issuers will have to consider the accuracy of their disclosure, whether or not boilerplate, as liability may attach to misleading disclosure and they may face claims that, for example, repurchases were meant to benefit management rather than shareholders.

8) This disclosure is meant to indicate whether the issuer has taken steps to prevent officers and directors from potentially benefiting from issuer repurchases in a manner that is not available to regular investors.

9) Note that the proposal requested comment on whether to define “announcement” for this purpose.

10) Under the existing conditions, a qualifying Rule 10b5-1 plan must (1) specify the amount, price and dates of purchases or sales, (2) include a formula, algorithm or computer program for determining the amount, price and dates, or (3) prohibit the insider from exercising control over the plan while prohibiting those controlling the plan from having material non-public information. The plan must also have been entered into in good faith and not as part of a scheme to circumvent the insider trading rules, and a plan can only be adopted and revised at a time when the insider does not have material non-public information. Furthermore, there are restrictions on an insider’s ability to engage in hedging transactions.

11) The proposal references academic studies purporting to show that “corporate insiders trading pursuant to Rule 10b5-1 consistently outperform trading of executives and directors not conducted under a Rule 10b5-1 trading arrangement” and notes concerns about issuers using Rule 10b5-1 plans to conduct share repurchases that have the effect of increasing the price of the issuer’s stock before sales by corporate insiders.

12) In the proposal, the term “officer” has the familiar Rule 16a-1(f) definition: president, principal financial officer, or principal accounting officer (or, if there is no such accounting officer, the controller), any vice-president of the issuer in charge of a principal business unit, division or function (such as sales, administration or finance), any other officer who performs a policy-making function, or any other person who performs similar policy-making functions for the issuer. Officers of the issuer’s parent(s) or subsidiaries shall be deemed officers of the issuer if they perform such policy-making functions for the issuer.

13) The proposal requested comment as to whether the proposed conditions would affect current practices with respect to tax qualified retirement savings plans, and tax withholding transactions with respect to equity compensation arrangements, such as stock options and restricted stock units. This suggests the SEC could view these practices as “trading arrangements.”

14) The proposal requested comment as to whether requiring this level of disclosure might encourage front-running of trades under the disclosed trading arrangements.

15) New Item 408(a) would not apply to foreign private issuers that file annual reports using Form 20-F because such issuers are not required to file quarterly reports on Form 10-Q.

16) This would also require a description of any modification or amendment of an existing Rule 10b5-1 trading arrangement because that is deemed the equivalent of terminating the existing arrangement and adopting a new arrangement.

17) Foreign private issuers would also be required to provide analogous disclosure in their annual reports pursuant to a new Item 16J in that form.

18) The proposal notes that an issuer could cross-reference to the particular components of its code of ethics that constitute insider trading policies and procedures, if any.

19) The term “option” would include stock options, stock appreciation rights and similar instruments with option-like features.

20) As defined in Item 402(a)(3) of Regulation S-K.

21) To eliminate the need for disclosure, issuers may consider adjusting their practices with respect to the timing of option grants (for example, instead of making grants when a window period opens upon the fling of a periodic report, waiting an extra 15 days).

22) The proposal does not propose to exempt smaller reporting companies or emerging growth companies from the proposed Item 402 disclosures. Smaller reporting companies and emerging growth companies would be permitted to limit their disclosures to a more limited list of named executive officers consistent with their other scaled disclosure requirements.

23) SEC v. Angelo Mozilo, 2009 WL 3807124 (Order Denying Defendant Angelo Mozilo’s Motion to Dismiss the Complaint) (Nov. 3, 2009).

24) In the Matter of Andover LLC, Admin. Proc. File No. 3-20125 (Oct. 15, 2020).

25) Employees’ Retirement System of Government of the Virgin Islands, et al. v. Blanford, et al., 794 F.3d 297 at 306 (2d Cir. 2015) (internal citations and quotation marks omitted).

26) See In re Gildan Activewear, Inc. Sec. Litig., 636 F.Supp.2d 261, 270 (S.D.N.Y. 2009); Plaintiffs bear the burden of demonstrating that Defendants’ stock sales are unusual. Acito v. IMCERA Grp., 47 F.3d 47, 54 (2d Cir. 1995).

27) Glaser v. The9 Ltd., 772 F. Supp. 2d 573 at 587 (S.D.N.Y. 2011).

28) See In re Able Labs. Sec. Litig., 2008 WL 1967509, at *28 (D.N.J. Mar. 24, 2008).

29) In re Lululemon Sec. Litig., 14 F.Supp.3d 553, 585 (S.D.N.Y. 2014).

30) Freudenberg v. E*TRADE Financial Corporation, 712 F.Supp.2d 171 at 199 (S.D.N.Y. 2010).

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Dechert LLP | Attorney Advertising

Written by:

Dechert LLP
Contact
more
less

Dechert LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide